These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10738713)

  • 1. [Bilateral malfunction of peripheral vestibular organs. Observations of 20 cases of Dandy syndrome].
    Lange G; Keller R
    Laryngorhinootologie; 2000 Feb; 79(2):77-80. PubMed ID: 10738713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inner ear changes with intracochlear gentamicin administration in Guinea pigs.
    Okuda T; Sugahara K; Shimogori H; Yamashita H
    Laryngoscope; 2004 Apr; 114(4):694-7. PubMed ID: 15064626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous gentamicin therapy in bilateral Menière disease].
    Jahnke K; Arweiler D
    Laryngorhinootologie; 1997 Sep; 76(9):519-22. PubMed ID: 9417178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM; Hehar SS; Bance ML; Rutka JA
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cochlear-vestibular ototoxicity by gentamicin. Report of a case and literature review].
    Pino Rivero V; Marcos García M; Keituqwa Yáñez T; González Palomino A; Trinidad Ruiz G; Pardo Romero G; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2004; 31(6):531-7. PubMed ID: 15663084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Skull vibratory test in partial vestibular lesions--influence of the stimulus frequency on the nystagmus direction].
    Dumas G; Perrin P; Morel N; N'Guyen DQ; Schmerber S
    Rev Laryngol Otol Rhinol (Bord); 2005; 126(4):235-42. PubMed ID: 16496550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral vestibulotoxicity due to systemic gentamicin therapy.
    Waterston JA; Halmagyi GM
    Acta Otolaryngol; 1998 Jul; 118(4):474-8. PubMed ID: 9726669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
    Ozluoglu LN; Akkuzu G; Ozgirgin N; Tarhan E
    Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Middle ear instillation of gentamicin and streptomycin in chinchillas: morphologic appraisal of selective ototoxicity.
    Chen JM; Kakigi A; Hirakawa H; Mount RJ; Harrison RV
    J Otolaryngol; 1999 Jun; 28(3):121-8. PubMed ID: 10410341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D; Patrikakos G
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intratympanic gentamicin in patients with Ménière's disease: analysis of our protocol].
    Martín Sanz E; Pérez Fernández N
    Acta Otorrinolaringol Esp; 2004; 55(6):270-6. PubMed ID: 15491114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K; Schönfeld U; Clarke AH
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [27 years experiences with transtympanic aminoglycoside treatment of Menière's disease].
    Lange G
    Laryngorhinootologie; 1995 Dec; 74(12):720-3. PubMed ID: 8579669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inner ear effects of topical gentamicin treatment in patients with Menière's disease.
    Bagger-Sjöbäck D; Bergenius J; Lundberg AM
    Am J Otol; 1990 Nov; 11(6):406-10. PubMed ID: 2285060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative vestibular diagnosis in therapy of Menière's disease].
    Westhofen M
    HNO; 1992 May; 40(5):176-80. PubMed ID: 1612933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology, and function.
    Hoffer ME; Allen K; Kopke RD; Weisskopf P; Gottshall K; Wester D
    Laryngoscope; 2001 Aug; 111(8):1343-57. PubMed ID: 11568567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.